Literature DB >> 26519348

XRCC1 rs25487 genetic variant and TP53 mutation at codon 249 predict clinical outcomes of hepatitis B virus-related hepatocellular carcinoma after hepatectomy: A cohort study for 10 years' follow up.

Long Yu1, Xiaoguang Liu1, Chuangye Han1, Sichong Lu1, Guangzhi Zhu1, Hao Su1, Wei Qi1, Xiwen Liao1, Tao Peng1.   

Abstract

AIM: To investigate the effects of rs25487 (the DNA repair gene: x-ray repair complementing defective repair in Chinese hamster cells 1 [XRCC1]) and codon 249 mutation (TP53 gene) on clinical outcomes of post-hepatectomy hepatitis B virus (HBV)-related HCC.
METHODS: The XRCC1 rs25487 polymorphism and TP53 mutation at codon 249 of 485 hepatitis B surface antigen positive patients subjected to hepatectomy were genotyped via direct sequencing. SPSS software version 16.0 (SPSS, Chicago, IL, USA) was used to calculate survival of HCC patients according to primary end-points.
RESULTS: The presence of at least one A allele (AA/AG) of rs25487 was associated with unfavorable prognosis (P = 0.005). Moreover, A allele (AA/AG) carriers were significantly associated with high risk of vascular invasion (P = 0.025) and regional invasion (P = 0.005). Differences were not significant between mutant and wild-type TP53 cases with overall survival (adjusted P = 0.400). Among the 485 participants, patients (n = 73) carrying both the A allele (AA/AG) of rs25487 and 249Ser TP53 mutation displayed decreased overall survival, compared with patients (n = 184) with the GG genotype of rs25487 and wild-type codon 249 (adjusted P = 0.007).
CONCLUSION: Polymorphisms of rs25487 may play a potential role in survival of HBV-related hepatocellular carcinoma patients following hepatectomy. While mutation at codon 249 of TP53 is not associated with HBV-related HCC survival in this study.
© 2015 The Japan Society of Hepatology.

Entities:  

Keywords:  codon 249; hepatitis B virus; hepatocellular carcinoma; prognosis; rs25487

Year:  2015        PMID: 26519348     DOI: 10.1111/hepr.12611

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  13 in total

1.  Genome-wide association study of the TP53 R249S mutation in hepatocellular carcinoma with aflatoxin B1 exposure and infection with hepatitis B virus.

Authors:  Chuangye Han; Tingdong Yu; Wei Qin; Xiwen Liao; Jianlu Huang; Zhengtao Liu; Long Yu; Xiaoguang Liu; Zhiwei Chen; Chengkun Yang; Xiangkun Wang; Shutian Mo; Guangzhi Zhu; Hao Su; Jiaquan Li; Xue Qin; Ying Gui; Zengnan Mo; Lequn Li; Tao Peng
Journal:  J Gastrointest Oncol       Date:  2020-12

Review 2.  Clinical applications of liquid biopsy as prognostic and predictive biomarkers in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA.

Authors:  Jie Li; Xu Han; Xiaona Yu; Zongzhen Xu; Guangsheng Yang; Bingqi Liu; Peng Xiu
Journal:  J Exp Clin Cancer Res       Date:  2018-09-03

Review 3.  A Comprehensive Evaluation of the Association between Polymorphisms in XRCC1, ERCC2, and XRCC3 and Prognosis in Hepatocellular Carcinoma: A Meta-Analysis.

Authors:  Yan Zhao; Erjiang Zhao; Junhui Zhang; Yuanyuan Chen; Junli Ma; Hailiang Li
Journal:  J Oncol       Date:  2019-06-12       Impact factor: 4.375

4.  EGFR and SYNE2 are associated with p21 expression and SYNE2 variants predict post-operative clinical outcomes in HBV-related hepatocellular carcinoma.

Authors:  Chuangye Han; Xiwen Liao; Wei Qin; Long Yu; Xiaoguang Liu; Gang Chen; Zhengtao Liu; Sicong Lu; Zhiwei Chen; Hao Su; Guangzhi Zhu; Zili Lu; Zhiming Liu; Xue Qin; Ying Gui; Zengnan Mo; Lequn Li; Tao Peng
Journal:  Sci Rep       Date:  2016-08-09       Impact factor: 4.379

5.  Prognostic value of Notch receptors in postsurgical patients with hepatitis B virus-related hepatocellular carcinoma.

Authors:  Tingdong Yu; Chuangye Han; Guangzhi Zhu; Xiwen Liao; Wei Qin; Chengkun Yang; Zhen Liu; Hao Su; Xiaoguang Liu; Long Yu; Zhengtao Liu; Sicong Lu; Zhiwei Chen; Yu Liang; Jianlu Huang; Xue Qin; Ying Gui; Jiaquan Li; Tao Peng
Journal:  Cancer Med       Date:  2017-05-31       Impact factor: 4.452

6.  Evaluation of candidate genes associated with hepatitis A and E virus infection in Chinese Han population.

Authors:  Maolin Gu; Jing Qiu; Daoxia Guo; Yunfang Xu; Xingxiang Liu; Chong Shen; Chen Dong
Journal:  Virol J       Date:  2018-03-20       Impact factor: 4.099

7.  Genome-wide association pathway analysis to identify candidate single nucleotide polymorphisms and molecular pathways associated with TP53 expression status in HBV-related hepatocellular carcinoma.

Authors:  Xiwen Liao; Long Yu; Xiaoguang Liu; Chuangye Han; Tingdong Yu; Wei Qin; Chengkun Yang; Guangzhi Zhu; Hao Su; Tao Peng
Journal:  Cancer Manag Res       Date:  2018-05-01       Impact factor: 3.989

8.  Mutations in NOTCH1 and nucleotide excision repair genes are correlated with prognosis of hepatitis B virus-associated hepatocellular carcinoma.

Authors:  Wen-Hui Su; Yuh-Shan Jou; Jia-Hao Zhang; Chun-Ming Ho; Dar-In Tai
Journal:  J Cancer       Date:  2018-06-23       Impact factor: 4.207

9.  The use of cell free DNA in the diagnosis of HCC.

Authors:  Bubu A Banini; Arun J Sanyal
Journal:  Hepatoma Res       Date:  2019-09-23

10.  MLH1 single-nucleotide variant in circulating tumor DNA predicts overall survival of patients with hepatocellular carcinoma.

Authors:  Soon Sun Kim; Jung Woo Eun; Ji-Hye Choi; Hyun Goo Woo; Hyo Jung Cho; Hye Ri Ahn; Chul Won Suh; Geum Ok Baek; Sung Won Cho; Jae Youn Cheong
Journal:  Sci Rep       Date:  2020-10-20       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.